๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

21 recruiting trials

for Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis NCT07695701Phase 41 site๐Ÿ“ St Louis Eidos Therapeutics, a BridgeBio company ยท Tests: Acoramidis (AG10) oral tablet A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites๐Ÿ“ Multiple Locations๐Ÿ“ Multiple Locations๐Ÿ“ Multiple Locations Bayer ยท Tests: Acoramidis (356 mg film-coated tablets) Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ San Francisco AstraZeneca ยท Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. NCT07448623Phase 11 site๐Ÿ“ Groningen Novo Nordisk A/S ยท Tests: Coramitug Quantitative-imaging in Cardiac Transthyretin Amyloidosis NCT05776212n/a1 site๐Ÿ“ Groningen University of Edinburgh ยท Tests: 18F-fluoride PET US Benchmarking Clinical Study NCT07215715n/a3 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston eMyosound SAS Multimodality Cardiac Imaging for Disease Progression in ATTR-CM NCT07112066NA1 site๐Ÿ“ Zurich Dominik Benz ยท Tests: FAPI tracer Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy NCT07791160n/a1 site๐Ÿ“ Many Locations Bayer ยท Tests: Acoramidis MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) NCT06128629Phase 3132 sites๐Ÿ“ Tucson๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Intellia Therapeutics ยท Tests: NTLA-2001, Placebo Thailand ATTR-CM Registry NCT06338696n/a8 sites๐Ÿ“ Bangkok๐Ÿ“ Bangkok๐Ÿ“ Bangkok Mahidol University ยท Tests: No intervention A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact. NCT06836011n/a8 sites๐Ÿ“ Graz๐Ÿ“ Vienna๐Ÿ“ Munich Medical University of Vienna Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant NCT06563895Phase 3104 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Eidos Therapeutics, a BridgeBio company ยท Tests: Acoramidis, Placebo oral tablet A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis NCT07298044Phase 426 sites๐Ÿ“ Sankt Pรถlten๐Ÿ“ Vienna๐Ÿ“ Vienna Bayer ยท Tests: Acoramidis Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM NCT07690436n/a20 sites๐Ÿ“ Palo Alto๐Ÿ“ Jacksonville๐Ÿ“ Chicago AstraZeneca DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting NCT07358078n/a27 sites๐Ÿ“ Tucson๐Ÿ“ Beverly Hills๐Ÿ“ La Jolla Alnylam Pharmaceuticals CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis NCT07207811Phase 3299 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Novo Nordisk A/S ยท Tests: NNC6019-0001, Placebo (NNC6019-0001) Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers NCT07306949Phase 416 sites๐Ÿ“ Bunkyล City๐Ÿ“ Bunkyล City๐Ÿ“ Kumamoto Alexion Pharmaceuticals, Inc. ยท Tests: Acoramidis TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT07052903Phase 3266 sites๐Ÿ“ La Jolla๐Ÿ“ Laguna Hills๐Ÿ“ Stanford Alnylam Pharmaceuticals ยท Tests: Nucresiran, Sterile Normal Saline (0.9% NaCl) Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study NCT07196839n/a1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center Phenotyping and Characterization of wtATTR-CM (TRACE 1) NCT06291805n/a1 site๐Ÿ“ Aarhus Steen Hvitfeldt Poulsen Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) NCT06318260Phase 1, Phase 21 site๐Ÿ“ Aarhus Steen Hvitfeldt Poulsen ยท Tests: Dobutrex
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy